Pidros CR Tablets (Levodropropizine)

Adult dose

Adults: Take 1 tablet per dose (equivalent to 90mg of levodropropizine) orally twice daily. This is an extended-release formulation; swallow it whole without splitting or crushing.

This medication should not be used in patients who have had an allergic reaction to this medication or its ingredients. It is also not safe for patients who have increased bronchial mucus secretion or certain genetic diseases such as ciliary dysfunction. Women who are pregnant or may become pregnant, as well as nursing mothers, should not use this medication. Patients with severe liver dysfunction should avoid using this medication. Since this medication contains lactose, patients with lactose intolerance or related genetic disorders should not take it. Patients with severe heart or renal dysfunction, elderly patients, and children should use this medication with caution. During the course of treatment with this medication, gastrointestinal symptoms such as nausea, dyspepsia, and constipation may occur, as well as central nervous system symptoms like drowsiness, headache, and dizziness. Rarely, symptoms such as eyelid swelling or positional dizziness have also been reported. Since this is a slow-release formulation, it is advisable to use other forms that can be split for children. In addition, this medication may enhance the effects of sedatives, so patients using such medications should be cautious. Care should be taken when performing tasks that require concentration, such as driving or operating machinery, as drowsiness may occur following the use of this medication, especially when taken with alcohol. Finally, this medication should be stored out of the reach of children, and transferring it to other containers should be avoided as it may cause quality degradation or accidents.

• Nausea
• indigestion
• constipation
• drowsiness
• headache
• dizziness
• positional vertigo
• eyelid swelling
• increased white blood cells in urine
• elevated ALT

This medication may be sensitive to air and moisture; thus, it should be stored in a tightly sealed container. The recommended storage temperature is between 1 degree and 30 degrees Celsius. This will help maintain the efficacy of the medication for a longer period.

Appearance

Biconvex tablets with a white to pale yellow upper layer and a white lower layer.

Package unit

30 tablets/bottle, 300 tablets/bottle